drug pricing – Page 4

ACHP Letter to Acting FDA Commissioner on the Accelerated Approval of Drugs and Biologics

ACHP sent a letter to FDA’s Acting Commissioner, Sara Brenner, with comments on the Expedited Program for Serious Conditions.

ACHP Letter to House Energy & Commerce Subcommittee on PBM Transparency

February 26, 2025 The Alliance of Community Health Plans (ACHP) sent a letter to the Energy and Commerce Subcommittee on Health with comments on pharmacy benefit manager (PBM) transparency, encouraging comprehensive reform to bring much-needed relief to patients at the pharmacy counter. The letter was sent ahead of the hearing An Examination of How Reining in PBMs Will Drive … Continued

ACHP Statement on Confirmation of Robert F. Kennedy Jr. as HHS Secretary

ACHP issued a statement regarding the confirmation of Robert F. Kennedy Jr. as Secretary of the U.S. Department of Health and Human Services.

ACHP Letter to CMS on CY 2026 MA and Part D Rate Notice

ACHP comments on the proposed methodological changes for CY 2026 for Medicare Advantage Capitation Rates and Part C and Part D Payment Policies.

Tag: drug pricing

ACHP Letter to Acting FDA Commissioner on the Accelerated Approval of Drugs and Biologics

ACHP Letter to House Energy & Commerce Subcommittee on PBM Transparency

ACHP Statement on Confirmation of Robert F. Kennedy Jr. as HHS Secretary

ACHP Letter to CMS on CY 2026 MA and Part D Rate Notice